Company intelligence / Profile preview

Stellen Medical

Saint Paul, Minnesota, United Statesstellenmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Stellen Medical commercializes advanced wound care products, notably GlucanPro 3000, an oat beta-glucan-based ointment that creates a moist, occlusive barrier for optimal healing. The company also manufactures porcine xenografts used in surgical soft tissue reconstruction. Their technologies are supported by over 25 years of experience and are distributed through direct sales and partnerships with major medical device companies[1][3][8].

Therapeutic areas: OtherDermatology
Modalities: DeviceBiologic
Industry: Consumable Medical Devices

Drug pipeline

4 assets

GlucanPro 3000

Commercial

Indications: Burns, Wounds, Donor sites

3 more assets in the full pipeline.

Request access →

Partnerships

Major medical device companies (not specified by name)

Beyond the preview

Go deeper on Stellen Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stellen Medical.

Explore the full profile